
The Securities and Exchange Commission has filed fraud charges against a Long Island operator and three affiliated entities over the sale of pre-IPO shares in some of the most sought-after private companies in the market. The complaint covers more than $74 million raised from over 800 mostly retail investors between December 2020 and June 2025, funnelled through funds that offered indirect exposure to SpaceX, Anthropic, Anduril, Perplexity, Stripe, Rubrik, Epic Games and Impossible Foods. What the regulator describes is not a fake-stock operation but a pricing one: investors were told they would pay no upfront fee or at most 12.5%, while the prices they actually paid ran on average 46% above what the operator had paid for the same positions. More than 100 sales agents worked the phones, and more than 100 of the people they reached were retirees. This piece walks through what the filing alleges, how the markup mechanism worked, why enforcement of this kind arguably strengthens the private-market access trade, and what it does not fix.
The Read
- The SEC alleges $74M raised from 800+ investors on pre-IPO shares carrying an average 46% undisclosed markup, up to 91%.
- Roughly $23M in upfront fees was collected, with $12M paid to sales agents and $4M going to the operator personally.
- Markups ran 64% on SpaceX ($595 to $975), 41% to 79% on Anthropic, 29% to 57% on Anduril and 27% to 45% on Perplexity.
A Manhattan Filing Covering Four and a Half Years of Raises
The regulator laid out the case in its announcement of charges against the boiler room operator and three affiliated entities, naming Andrew Spaventa alongside The Spaventa Group, TSG Capital Advisors and TSG Alpha Partners. The raises ran from December 2020 through June 2025.
Scale is what separates this from a boutique placement. More than $74 million came from over 800 investors, and more than 650 of them put in $100,000 or less. That distribution tells you the money was raised in small tickets from people whose portfolios could not absorb the loss.
The distribution machine was built for volume. Over 100 sales agents cold-called thousands of prospects with scripted pitches and high-pressure tactics, and more than 100 of the investors reached were retirees. Most of them have not recovered what they put in.
The complaint was filed in the U.S. District Court for the Southern District of New York and charges violations of the antifraud, securities registration and broker-dealer registration provisions of the Securities Act of 1933. The SEC is seeking permanent injunctions, disgorgement with prejudgment interest, civil penalties and conduct-based injunctions against Spaventa, who denies the allegations.

A 46% Average Markup Behind a 12.5% Fee Promise
The pricing mechanism applied to these pre-IPO shares is simple enough to explain in one line, which is exactly why it worked. Investors were told the funds charged either nothing upfront or a maximum of 12.5%. The actual entry prices sat on average 46% above the acquisition cost, and reached 91% at the extreme.
Run that spread through the names and the arithmetic gets concrete. SpaceX positions acquired at $595 were sold on at $975, a 64% markup. Anthropic exposure carried 41% to 79%, Anduril 29% to 57%, Perplexity 27% to 45%. Anthropic itself flagged earlier this year that it was aware of funds claiming to offer indirect access to its stock, an issue we covered when investors started questioning the $965B valuation attached to its listing.
The money trail explains the incentive structure. Roughly $23 million in upfront fees was collected across the funds, of which more than $12 million went to sales agents as commissions and around $4 million went to Spaventa personally. A commission pool that size funds a hundred callers indefinitely.
Here is why the markup mattered more than the underlying pick. An investor buying SpaceX at a 64% premium needed the company to appreciate 64% before breaking even, on an asset with no daily mark and no exit until a listing. The SpaceX float has since been volatile in public hands too, as the lockup schedule showed when the stock printed a record low at $115 into the unlock.
Enforcement Repricing the Cost of Private-Market Access
The constructive read is that this case draws a line the market has needed for two years. Demand for pre-IPO shares is real, and the products serving it have multiplied faster than the disclosure standards around them. A fraud charge attached to the fee layer rather than the asset itself tells intermediaries exactly where the boundary sits.
Regulated venues stand to benefit from that clarity. Every dollar that stops flowing into a phone-sold fund at a 46% blind premium is a dollar available to a structure with a published fee, a named custodian and a redemption path. The SEC has been building that frame in parallel, including when it opened a public consultation on rules for innovative exchange-traded products.
The disgorgement request matters for a second reason. If the SEC recovers the roughly $23 million in fees, the recovery rate on this case sets a reference point for how much of a boiler-room raise investors can realistically expect back. That number will be quoted in every similar action that follows.
There is also a demand-side argument buried in the case file. Eight hundred people paid a 46% premium for exposure to eight private companies, which is a fairly loud statement about how badly retail wants access to assets it currently cannot reach at a fair price.
The Access Gap the Complaint Leaves Untouched
The harder read is that enforcement removes an operator without removing the conditions that created it. Retail investors still have no clean route into private shares before a listing, and the companies involved were still among the most requested names in the market. A vacuum that produced one hundred-agent operation can produce another.
The timing of the raises reinforces that point. The scheme ran through June 2025, four and a half years after it started, and the SEC action lands more than a year after the last raise. Investors who bought in 2021 held an illiquid position for the entire life of the fraud before learning what they had paid.
Recovery prospects are the weakest part of the file for anyone still holding. The complaint notes most investors have not recouped their investments, and civil penalties are paid to the government, not to buyers. Disgorgement is the only lever pointing back toward them, and it is capped at what can actually be traced.
The asymmetry to price is therefore between transparency and access. Enforcement makes the fee layer visible after the fact, while the structural shortage of legitimate pre-IPO shares for smaller investors stays exactly where it was. Anyone offered private-market exposure over the phone now has one usable test: ask what the seller paid for the position, and treat a refusal as the answer.
More to come.




